Voyageur Pharmaceuticals Ltd. (OTCMKTS:VYYRF – Get Free Report) was the recipient of a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 25 shares, a drop of 99.9% from the April 30th total of 30,720 shares. Based on an average daily trading volume, of 6,568 shares, the short-interest ratio is currently 0.0 days.
Voyageur Pharmaceuticals Price Performance
Shares of Voyageur Pharmaceuticals stock opened at $0.06 on Friday. Voyageur Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.24. The stock has a fifty day moving average price of $0.09 and a 200-day moving average price of $0.10.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals, Inc is a biopharmaceutical company specializing in advanced drug-delivery technologies and contract development services. The company focuses on formulating and optimizing therapeutic compounds to enhance stability, bioavailability and controlled-release properties. By leveraging proprietary polymer- and lipid-based delivery platforms, Voyageur aims to partner with pharmaceutical and biotechnology firms to address formulation challenges in high-value therapeutic areas, including oncology, endocrinology and central nervous system disorders.
The company’s core offerings include formulation development, analytical testing, preclinical evaluation and small-scale manufacturing support.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
